[1]
E. P. Borrelli, PhD, PharmD, MBA, J. Bratberg, PharmD, FAPhA, M. L. Greaney, PhD, MPH, and S. J. Kogut, PhD, MBA, RPh, “Tramadol utilization among patients with higher risk of adverse drug events: A claims analysis of commercially insured and Medicare Advantage members”, J of Opioid Management, vol. 19, no. 3, pp. 257–271, Apr. 2023.